Cite

HARVARD Citation

    Prampolini, C. et al. (2021). Immunohistochemical detection of "ex novo" HLA‐DR in tumor cells determines clinical outcome in laryngeal cancer patients. HLA. pp. 517-524. [Online]. 
  
Back to record